Overdiagnosis due to breast cancer screening: updated estimates of the Helsinki service study in Finland View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2014-08-14

AUTHORS

S Heinävaara, T Sarkeala, A Anttila

ABSTRACT

Background:Overdiagnosis is the most important adverse event of breast cancer screening with the estimates ranging from 0% to 40–50% depending on invitational age and methods. We updated the estimates of overdiagnosis in Helsinki service screening study in Finland by comparing the observed and expected cumulative incidence of all breast carcinomas and invasive breast carcinomas.Methods:Women aged 50–59 years have been invited to Helsinki service screening since 1986. The incidence of breast carcinoma in the first invited birth cohorts born in 1935–1939 was compared with older, non-invited cohorts. The minimum follow-up time of the invitees after the last screening round was 14 years. Expected cumulative incidence rates were estimated with two alternative approaches.Results:For both any breast carcinoma and invasive breast carcinoma, the estimates of overdiagnosis varied from 5% (95% CI=−1, 11%) to 7% (95% CI=1, 13%) depending on the approach.Conclusions:Our estimates of overdiagnosis are of the same magnitude than other plausible estimates in Europe. Both alternative approaches produced similar estimates for the expected cumulative incidence, which increased the confidence in the estimates of overdiagnosis. More... »

PAGES

1463-1468

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/bjc.2014.413

DOI

http://dx.doi.org/10.1038/bjc.2014.413

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1013800527

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25121953


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Ductal, Breast", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Intraductal, Noninfiltrating", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Early Detection of Cancer", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "False Positive Reactions", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Finland", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Incidence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mammography", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Finnish Cancer Registry, Mass Screening Registry, Unioninkatu 22, 00130, Helsinki, Finland", 
          "id": "http://www.grid.ac/institutes/grid.424339.b", 
          "name": [
            "Finnish Cancer Registry, Mass Screening Registry, Unioninkatu 22, 00130, Helsinki, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hein\u00e4vaara", 
        "givenName": "S", 
        "id": "sg:person.01051607263.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051607263.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Finnish Cancer Registry, Mass Screening Registry, Unioninkatu 22, 00130, Helsinki, Finland", 
          "id": "http://www.grid.ac/institutes/grid.424339.b", 
          "name": [
            "Finnish Cancer Registry, Mass Screening Registry, Unioninkatu 22, 00130, Helsinki, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sarkeala", 
        "givenName": "T", 
        "id": "sg:person.0735360663.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0735360663.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Finnish Cancer Registry, Mass Screening Registry, Unioninkatu 22, 00130, Helsinki, Finland", 
          "id": "http://www.grid.ac/institutes/grid.424339.b", 
          "name": [
            "Finnish Cancer Registry, Mass Screening Registry, Unioninkatu 22, 00130, Helsinki, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Anttila", 
        "givenName": "A", 
        "id": "sg:person.01220417437.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01220417437.14"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/bjc.2013.177", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039489739", 
          "https://doi.org/10.1038/bjc.2013.177"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/bcr3427", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014388555", 
          "https://doi.org/10.1186/bcr3427"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6604638", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041622795", 
          "https://doi.org/10.1038/sj.bjc.6604638"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6604762", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042959404", 
          "https://doi.org/10.1038/sj.bjc.6604762"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.2013.427", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006739429", 
          "https://doi.org/10.1038/bjc.2013.427"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10552-011-9867-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041773715", 
          "https://doi.org/10.1007/s10552-011-9867-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-009-0701-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006572049", 
          "https://doi.org/10.1007/s10549-009-0701-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/bcr3090", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023293127", 
          "https://doi.org/10.1186/bcr3090"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-08-14", 
    "datePublishedReg": "2014-08-14", 
    "description": "Background:Overdiagnosis is the most important adverse event of breast cancer screening with the estimates ranging from 0% to 40\u201350% depending on invitational age and methods. We updated the estimates of overdiagnosis in Helsinki service screening study in Finland by comparing the observed and expected cumulative incidence of all breast carcinomas and invasive breast carcinomas.Methods:Women aged 50\u201359 years have been invited to Helsinki service screening since 1986. The incidence of breast carcinoma in the first invited birth cohorts born in 1935\u20131939 was compared with older, non-invited cohorts. The minimum follow-up time of the invitees after the last screening round was 14 years. Expected cumulative incidence rates were estimated with two alternative approaches.Results:For both any breast carcinoma and invasive breast carcinoma, the estimates of overdiagnosis varied from 5% (95% CI=\u22121, 11%) to 7% (95% CI=1, 13%) depending on the approach.Conclusions:Our estimates of overdiagnosis are of the same magnitude than other plausible estimates in Europe. Both alternative approaches produced similar estimates for the expected cumulative incidence, which increased the confidence in the estimates of overdiagnosis.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/bjc.2014.413", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "111"
      }
    ], 
    "keywords": [
      "estimates of overdiagnosis", 
      "invasive breast carcinoma", 
      "breast carcinoma", 
      "cumulative incidence", 
      "last screening round", 
      "important adverse events", 
      "cumulative incidence rate", 
      "breast cancer screening", 
      "minimum follow", 
      "adverse events", 
      "cancer screening", 
      "screening round", 
      "incidence rate", 
      "breast cancer", 
      "overdiagnosis", 
      "birth cohort", 
      "carcinoma", 
      "incidence", 
      "cohort", 
      "service studies", 
      "follow", 
      "cancer", 
      "years", 
      "women", 
      "age", 
      "study", 
      "invitees", 
      "screening", 
      "same magnitude", 
      "alternative approach", 
      "similar estimates", 
      "Finland", 
      "services", 
      "rate", 
      "events", 
      "rounds", 
      "estimates", 
      "confidence", 
      "time", 
      "plausible estimates", 
      "approach", 
      "method", 
      "magnitude", 
      "Europe"
    ], 
    "name": "Overdiagnosis due to breast cancer screening: updated estimates of the Helsinki service study in Finland", 
    "pagination": "1463-1468", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1013800527"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/bjc.2014.413"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25121953"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/bjc.2014.413", 
      "https://app.dimensions.ai/details/publication/pub.1013800527"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:58", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_647.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/bjc.2014.413"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bjc.2014.413'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bjc.2014.413'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bjc.2014.413'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bjc.2014.413'


 

This table displays all metadata directly associated to this object as RDF triples.

203 TRIPLES      21 PREDICATES      90 URIs      74 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/bjc.2014.413 schema:about N3062d424c1694f0bb84aff7aa55745a1
2 N43069a2b247844f5b2c3ab34efdc6117
3 N4cd078ce224b400fa4953d5d490543e6
4 N53fc0e1a73454cb8850adf30d3941c15
5 N733f04a363db44958d77f185f2c780a4
6 N99394324187c4684bfe147a3d29ecb97
7 Nb1a4ef893c22471c85aad4e0490639c9
8 Nc2e631292d164ba2a9cd392f4d1a3cc8
9 Nd0efc242acb24676b6a2e7498b1fc5d3
10 Nd1cfdcea0df247cfa6b61cb4423e95b5
11 Nd9463fb1dbcf45a49d8d42d4cfe8e024
12 Ne4666ab40aa54beda1fff3fa7eb06638
13 Ne8c47764ca704025b0b7abb3173552a3
14 anzsrc-for:11
15 anzsrc-for:1117
16 schema:author N4ad1166c6b7043ff948a2ad495c42f67
17 schema:citation sg:pub.10.1007/s10549-009-0701-x
18 sg:pub.10.1007/s10552-011-9867-8
19 sg:pub.10.1038/bjc.2013.177
20 sg:pub.10.1038/bjc.2013.427
21 sg:pub.10.1038/sj.bjc.6604638
22 sg:pub.10.1038/sj.bjc.6604762
23 sg:pub.10.1186/bcr3090
24 sg:pub.10.1186/bcr3427
25 schema:datePublished 2014-08-14
26 schema:datePublishedReg 2014-08-14
27 schema:description Background:Overdiagnosis is the most important adverse event of breast cancer screening with the estimates ranging from 0% to 40–50% depending on invitational age and methods. We updated the estimates of overdiagnosis in Helsinki service screening study in Finland by comparing the observed and expected cumulative incidence of all breast carcinomas and invasive breast carcinomas.Methods:Women aged 50–59 years have been invited to Helsinki service screening since 1986. The incidence of breast carcinoma in the first invited birth cohorts born in 1935–1939 was compared with older, non-invited cohorts. The minimum follow-up time of the invitees after the last screening round was 14 years. Expected cumulative incidence rates were estimated with two alternative approaches.Results:For both any breast carcinoma and invasive breast carcinoma, the estimates of overdiagnosis varied from 5% (95% CI=−1, 11%) to 7% (95% CI=1, 13%) depending on the approach.Conclusions:Our estimates of overdiagnosis are of the same magnitude than other plausible estimates in Europe. Both alternative approaches produced similar estimates for the expected cumulative incidence, which increased the confidence in the estimates of overdiagnosis.
28 schema:genre article
29 schema:isAccessibleForFree true
30 schema:isPartOf N21b652adf25b450399f1c337560640cc
31 N36aa8854ea9d4e37b1c6eb5a53bb8232
32 sg:journal.1017082
33 schema:keywords Europe
34 Finland
35 adverse events
36 age
37 alternative approach
38 approach
39 birth cohort
40 breast cancer
41 breast cancer screening
42 breast carcinoma
43 cancer
44 cancer screening
45 carcinoma
46 cohort
47 confidence
48 cumulative incidence
49 cumulative incidence rate
50 estimates
51 estimates of overdiagnosis
52 events
53 follow
54 important adverse events
55 incidence
56 incidence rate
57 invasive breast carcinoma
58 invitees
59 last screening round
60 magnitude
61 method
62 minimum follow
63 overdiagnosis
64 plausible estimates
65 rate
66 rounds
67 same magnitude
68 screening
69 screening round
70 service studies
71 services
72 similar estimates
73 study
74 time
75 women
76 years
77 schema:name Overdiagnosis due to breast cancer screening: updated estimates of the Helsinki service study in Finland
78 schema:pagination 1463-1468
79 schema:productId N3cee8b2667cf4e46928ad72042e0242c
80 N4d79beaa8788483eae8676a1042746db
81 Nb2a705ac1dc34c6089fea010522afd8b
82 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013800527
83 https://doi.org/10.1038/bjc.2014.413
84 schema:sdDatePublished 2022-09-02T15:58
85 schema:sdLicense https://scigraph.springernature.com/explorer/license/
86 schema:sdPublisher N9c1bb1df82fb4369ba4c64cd04dab8c5
87 schema:url https://doi.org/10.1038/bjc.2014.413
88 sgo:license sg:explorer/license/
89 sgo:sdDataset articles
90 rdf:type schema:ScholarlyArticle
91 N21b652adf25b450399f1c337560640cc schema:volumeNumber 111
92 rdf:type schema:PublicationVolume
93 N3062d424c1694f0bb84aff7aa55745a1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Aged
95 rdf:type schema:DefinedTerm
96 N36aa8854ea9d4e37b1c6eb5a53bb8232 schema:issueNumber 7
97 rdf:type schema:PublicationIssue
98 N3cee8b2667cf4e46928ad72042e0242c schema:name pubmed_id
99 schema:value 25121953
100 rdf:type schema:PropertyValue
101 N43069a2b247844f5b2c3ab34efdc6117 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Adult
103 rdf:type schema:DefinedTerm
104 N4ad1166c6b7043ff948a2ad495c42f67 rdf:first sg:person.01051607263.28
105 rdf:rest Nb7450e8bfc1148659d9a130662e731aa
106 N4cd078ce224b400fa4953d5d490543e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Breast Neoplasms
108 rdf:type schema:DefinedTerm
109 N4d79beaa8788483eae8676a1042746db schema:name dimensions_id
110 schema:value pub.1013800527
111 rdf:type schema:PropertyValue
112 N53fc0e1a73454cb8850adf30d3941c15 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name False Positive Reactions
114 rdf:type schema:DefinedTerm
115 N733f04a363db44958d77f185f2c780a4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Mammography
117 rdf:type schema:DefinedTerm
118 N99394324187c4684bfe147a3d29ecb97 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Early Detection of Cancer
120 rdf:type schema:DefinedTerm
121 N9c1bb1df82fb4369ba4c64cd04dab8c5 schema:name Springer Nature - SN SciGraph project
122 rdf:type schema:Organization
123 Nb1a4ef893c22471c85aad4e0490639c9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Middle Aged
125 rdf:type schema:DefinedTerm
126 Nb2a705ac1dc34c6089fea010522afd8b schema:name doi
127 schema:value 10.1038/bjc.2014.413
128 rdf:type schema:PropertyValue
129 Nb7450e8bfc1148659d9a130662e731aa rdf:first sg:person.0735360663.07
130 rdf:rest Nf529eae1cff14fb6a3e445144ce90e4b
131 Nc2e631292d164ba2a9cd392f4d1a3cc8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Incidence
133 rdf:type schema:DefinedTerm
134 Nd0efc242acb24676b6a2e7498b1fc5d3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Finland
136 rdf:type schema:DefinedTerm
137 Nd1cfdcea0df247cfa6b61cb4423e95b5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Humans
139 rdf:type schema:DefinedTerm
140 Nd9463fb1dbcf45a49d8d42d4cfe8e024 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Female
142 rdf:type schema:DefinedTerm
143 Ne4666ab40aa54beda1fff3fa7eb06638 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Carcinoma, Intraductal, Noninfiltrating
145 rdf:type schema:DefinedTerm
146 Ne8c47764ca704025b0b7abb3173552a3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Carcinoma, Ductal, Breast
148 rdf:type schema:DefinedTerm
149 Nf529eae1cff14fb6a3e445144ce90e4b rdf:first sg:person.01220417437.14
150 rdf:rest rdf:nil
151 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
152 schema:name Medical and Health Sciences
153 rdf:type schema:DefinedTerm
154 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
155 schema:name Public Health and Health Services
156 rdf:type schema:DefinedTerm
157 sg:journal.1017082 schema:issn 0007-0920
158 1532-1827
159 schema:name British Journal of Cancer
160 schema:publisher Springer Nature
161 rdf:type schema:Periodical
162 sg:person.01051607263.28 schema:affiliation grid-institutes:grid.424339.b
163 schema:familyName Heinävaara
164 schema:givenName S
165 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051607263.28
166 rdf:type schema:Person
167 sg:person.01220417437.14 schema:affiliation grid-institutes:grid.424339.b
168 schema:familyName Anttila
169 schema:givenName A
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01220417437.14
171 rdf:type schema:Person
172 sg:person.0735360663.07 schema:affiliation grid-institutes:grid.424339.b
173 schema:familyName Sarkeala
174 schema:givenName T
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0735360663.07
176 rdf:type schema:Person
177 sg:pub.10.1007/s10549-009-0701-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1006572049
178 https://doi.org/10.1007/s10549-009-0701-x
179 rdf:type schema:CreativeWork
180 sg:pub.10.1007/s10552-011-9867-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041773715
181 https://doi.org/10.1007/s10552-011-9867-8
182 rdf:type schema:CreativeWork
183 sg:pub.10.1038/bjc.2013.177 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039489739
184 https://doi.org/10.1038/bjc.2013.177
185 rdf:type schema:CreativeWork
186 sg:pub.10.1038/bjc.2013.427 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006739429
187 https://doi.org/10.1038/bjc.2013.427
188 rdf:type schema:CreativeWork
189 sg:pub.10.1038/sj.bjc.6604638 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041622795
190 https://doi.org/10.1038/sj.bjc.6604638
191 rdf:type schema:CreativeWork
192 sg:pub.10.1038/sj.bjc.6604762 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042959404
193 https://doi.org/10.1038/sj.bjc.6604762
194 rdf:type schema:CreativeWork
195 sg:pub.10.1186/bcr3090 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023293127
196 https://doi.org/10.1186/bcr3090
197 rdf:type schema:CreativeWork
198 sg:pub.10.1186/bcr3427 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014388555
199 https://doi.org/10.1186/bcr3427
200 rdf:type schema:CreativeWork
201 grid-institutes:grid.424339.b schema:alternateName Finnish Cancer Registry, Mass Screening Registry, Unioninkatu 22, 00130, Helsinki, Finland
202 schema:name Finnish Cancer Registry, Mass Screening Registry, Unioninkatu 22, 00130, Helsinki, Finland
203 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...